Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00812929 · ClinicalTrials.gov registry record · Phase 2
A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 47
- Enrollment target
NCT00812929 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 47 participants.
The verdict
NCT00812929, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 47 participants
- Enrollment target
Study Summary
This study is intended to determine the dose response and duration of action of GSK2190915 in mild asthmatic adult subjects who experience exercise-induced bronchoconstriction.
Interventions
- DRUG Placebo
- DRUG GSK2190915
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2008-12-01 |
| Est. Completion | 2009-07-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00812929
The ClinicalTrials.gov registry entry for NCT00812929 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00812929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00812929 about?
NCT00812929 is a clinical study titled "A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise". This study is intended to determine the dose response and duration of action of GSK2190915 in mild asthmatic adult subjects who experience exercise-induced bronchoconstriction.
What is the current status of trial NCT00812929?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 47 participants. The study started on 2008-12-01. Estimated completion is 2009-07-15.
What interventions are being tested in trial NCT00812929?
The interventions under investigation include: Placebo (DRUG), GSK2190915 (DRUG).
Who is sponsoring clinical trial NCT00812929?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.